| Literature DB >> 35463986 |
Feng Du1,2, Wei Zhang1, Hua Mao2, Yanli Guo2, Meiqin Guo2, Yuming Lu2, Min Chen2, Zhongxin Sha2.
Abstract
Objective: By detecting the levels of external counterpulsation combined with exercise therapy on the levels of moesin, angiopoietin-like protein2 (Angptl 2), angiopoietin-like protein (Angptl 3), hypoxia inducible factor-1α (HIF-1α), and RNA-34a (miR-34a) in patients with coronary artery occlusive disease, the effect of external counterpulsation combined with exercise therapy on the establishment of occluded coronary collateral circulation was studied.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35463986 PMCID: PMC9020965 DOI: 10.1155/2022/1336184
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.246
The qRT-PCR primer sequence design.
| Gene | Forward primer (5′-3′) | Reverse primer (5′-3′) | Sequence length (bp) |
|---|---|---|---|
| U6 | ATTGGAACGATACAGAGAAGATT | GGAACGCTTCACGAATTTG | 212 |
| miR-34a | ACGCTCAGTTAATGCTAATCGTGATA | ATTCCATGTCCACTGTGTCTG | 241 |
Comparison of general material between the two patient groups (± s) (%).
| Project | Control group | Treatment group |
|
|---|---|---|---|
| Sex ( | |||
| Male | 48 (53.9) | 40 (51.9) | 0.797 |
| Female | 41 (46.1) | 37 (48.1) | 0.991 |
| Age(years) | 69.38 ± 9.15 | 70.81 ± 9.68 | 0.281 |
| BMI (kg/m2) | 27.4 ± 6.2 | 26.9 ± 5.4 | 0.460 |
| Systolic pressure (mmHg) | 146 ± 11 | 149 ± 13 | 0.114 |
| TC (mmol/L) | 6.08 ± 0.15 | 6.12 ± 0.13 | 0.270 |
| LDL-C(mmol/L) | 3.58 ± 0.12 | 3.56 ± 0.11 | 0.450 |
| HR (bpm) | 73.89 ± 13.39 | 73.60 ± 16.24 | 0.333 |
| Cr (umol/L) | 69.6 ± 8.2 | 68.7 ± 9.1 | 0.160 |
| FPG (mmol/L) | 5.41 ± 0.21 | 5.38 ± 0.26 | 0.390 |
| Location of occlusive lesions ( | |||
| Left anterior descending branch | 34 (38.2) | 31 (40.3) | 0.070 |
| Arteriae coronaria dextra | 32 (35.9) | 31 (40.3) | 0.096 |
| Left cyclotron branch | 18 (20.2) | 11 (14.3) | 0.163 |
| Other locations | 5 (5.6) | 4 (5.2) | 0.058 |
| The number of lateral branches of the lesion (n/%) | |||
| Single branch | 39 (43.8) | 26 (33.8) | 0.083 |
| Double branch | 34 (38.2) | 31 (40.3) | 0.070 |
| Three branch | 16 (18.0) | 20 (26.0) | 0.370 |
| Duration of angina pectoris (month) | 8.9 ± 6.8 | 7.1 ± 6.2 | 0.552 |
| Angina CCS grade ( | |||
| 0 | 0 (0) | 0 (0) | 0.901 |
| I | 50 (56.2) | 34 (44.2) | 0.470 |
| II | 39 (43.8) | 43 (55.8) | 0.525 |
| III | 0 | 0 (0) | |
| Coronary risk factor ( | |||
| Smoke | 23 (59.0) | 46 (59.7) | 0.092 |
| Hypercholesterolemia | 78 (87.6) | 68 (88.3) | 0.530 |
| Family history of coronary heart disease | 71 (79.8) | 57 (74.0) | 0.382 |
| Obesity with BMI >28 kg/m2 ( | 43 (48.3) | 43 (55.8) | 0.510 |
| Drugs ( | |||
| Clopidogrel | 34 (38.2) | 31 (40.3) | 0.071 |
| Nitrates | 53 (59.6) | 46 (59.7) | 0.062 |
| Adventitia receptor blocker | 55 (61.8) | 40 (51.9) | 0.182 |
| Ca2+ channel blocker | 46 (51.7) | 37 (48.1) | 0.207 |
| ACEI class drugs | 59 (66.3) | 49 (63.6) | 0.371 |
| Statins | 48 (53.9) | 40 (51.9) | 0.210 |
Notes: TC: triglycerides; LDL-C: low-density lipoprotein cholesterol; HR: heart rate; Cr: creatinine clearance; FPG: fasting plasma glucose; CCS: Canadian Cardiovascular Society.
Comparison of the IMR and CFR levels between the treatment and control groups.
| Groups |
| IMR | CFR | ||
|---|---|---|---|---|---|
| Prior treatment | Post-treatment | Prior treatment | Post-treatment | ||
| Control group | 89 | 52.37 ± 1.43 | 28.241 ± 5.87▲ | 1.97 ± 0.25 | 2.72 ± 0.17▲ |
| Experimental group | 77 | 41.25 ± 5.01 | 23.19 ± 3.64▲ | 1.99 ± 0.27 | 3.08 ± 0.23▲ |
|
| >0.05 | <0.05 | >0.05 | <0.05 | |
▲P was <0.05.
Figure 1Comparison of CFR levels between the control and treated groups.
The Rentrop scores were compared between the two patient groups.
| Project | Control group ( | Treatment group ( |
|
|---|---|---|---|
| Rentrop score ≧2 (example/%) | 62 (69.7) | 71 (92.2) | 0.014 |
| Rentrop score <2 (example/%) | 27 (30.3) | 6 (7.8) | 0.029 |
The moesin antibody positive rate was (%) in both groups.
| Project | Control group ( | Treatment group |
|
|---|---|---|---|
| Positive (example/%) | 80 (89.9) | 68 (88.3) | 0.907 |
| Negative: (example:/%) | 9 (10.1) | 9 (11.7) | 0.838 |
| Ln(OD) | -1.532 ± 0.312 | -1.961 ± 0.318 | 0.012 |
Detection of serum Angptl 2, Angptl 3, HIF-1, and miR-34a ().
| Project | Control group ( | Treatment group ( |
|
|---|---|---|---|
| Angptl 2 (ng/mL) | 7.19 ± 1.24 | 5.62 ± 1.04 | 0.072 |
| Angptl 3 (ng/mL) | 4.31 ± 2.01 | 3.01 ± 1.21 | 0.031 |
| HIF-1 | 20.62 ± 4.53 | 27.41 ± 6.01 | 0.016 |
| miR-34a | 0.94 ± 0.11 | 0.52 ± 0.11 | 0.021 |
Compared with that before treatment, the ▲P was <0.05.